Trellis Bioscience, Inc.

City:

Redwood City, California

Country:

United States

Published Applications:

Last publication date:

2025-06-19

Patent Grants:

Last grant date:

2026-06-02

Top Inventors for applications by Trellis Bioscience, Inc.

These are the the leading inventors for applications assigned to Trellis Bioscience, Inc.:

Lawrence M. KAUVAR 5 San Francisco, CA United States
Ralph A. Tripp 2 Redwood City, CA United States
Urs A. Ramel 2 Redwood City, CA United States
Lawrence M. Kauvar 2 Redwood City, CA United States

Leslie P. Jones 2 Redwood City, CA United States
Milton J. Friedman 2 Alameda, CA United States
Stote Ellsworth 2 Redwood City, CA United States
Joel Blatt 2 Redwood City, CA United States

Stefan RYSER 1 Menlo Park, CA United States
Mikhail Gishizky 1 Redwood City, CA United States
Angeles Estelles 1 Redwood City, CA United States
Lawrence Kauvar 1 Redwood City, CA United States

Rebecca Dubois 1 Santa Cruz, CA United States
Stefan Ryser 1 Redwood City, CA United States
Michael WITTEKIND 1 Yonkers, NY United States
Adam VIGIL 1 Yonkers, NY United States

Stas FEDECHKIN 1 Santa Cruz, CA United States
Angeles ESTELLES 1 Belmont, CA United States

Recent patent applications by Trellis Bioscience, Inc.

Trellis Bioscience, Inc. based in Redwood City, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-06-19

US20250195636A1

Human necessities

RSV PASSIVE AND ACTIVE VACCINES

#2 | 2024-08-01

US20240254258A1

Chemistry; metallurgy

ANTI-ALK ANTIBODIES AND USES THEREOF

#3 | 2024-07-11

US20240226877A9

Performing operations; transporting

Diagnostics for Emerging Disease

#4 | 2024-05-09

US20240150414A1

Chemistry; metallurgy

CONFORMATIONAL EPITOPES IN RESPIRATORY SYNCYTIAL VIRUS G PROTEIN CENTRAL CONSERVED REGION

#5 | 2024-04-25

US20240131508A1

Performing operations; transporting

Diagnostics for Emerging Disease

#6 | 2022-06-30 ✅ Patent 12,643,941 granted on 2026-06-02

US20220204600A1

Chemistry; metallurgy

THERAPEUTIC PROTEIN FORMULATIONS COMPRISING ANTI-DNABII ANTIBODIES AND USES THEREOF

#7 | 2022-04-14 ✅ Patent 12,491,245 granted on 2025-12-09

US20220111049A1

Human necessities

ANTIBODIES USEFUL IN PASSIVE INFLUENZA IMMUNIZATION, AND COMPOSITIONS, COMBINATIONS AND METHODS FOR USE THEREOF

#8 | 2021-09-02 ✅ Patent 12,246,063 granted on 2025-03-11

US20210268096A1

Human necessities

Immunogen providing an extended protective lifetime against respiratory syncytial virus (RSV) and vaccines thereof

Also check out Trellis Bioscience, Inc.'s (Redwood City, United States) applicant profile with 7 patent applications submitted.

AssigneeID:

325472 ⎘